MUHC research news
Dr. Pierre Chartrand, Acting President of the Canadian Institutes of Health Research (CIHR), along with CIHR's Governing Council, made the announcment today.
McGill University Health Centre sarcoma patients, medical staff and researchers have teamed up to hold the first annual MUHC Sarcoma Day.
An animal study on sildenafil (Viagra) reveals a potential new treatment for the cardiac complications in patients with this major disease
Did you know? Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world. MS is the most common neurological disease affecting young adults in Canada, and every day three more people in Canada are diagnosed with MS. MS is most often diagnosed in young adults aged 15 to 40, but it can also affect children -- some as young as two years old.
New studies from a team of researchers from the Research Institute of the MUHC and McGill University show that the environment surrounding breast cancer cells plays a crucial role in determining whether tumor cells grow and migrate or whether they fade away.
A new fundamental mechanism of how tumour cells communicate has just been discovered by the team of Dr. Janusz Rak at the Research Institute of the McGill University Health Centre (MUHC) in collaboration with Dr Guha from the University of Toronto.
The American Diabetes Association and the American College of Cardiology today recognized the key importance of an additional predictor of cardiovascular disease - a protein called apolipoprotein B (apoB).
The McGill University Health Centre Research Institute and the University of Calgary in collaboration with Centennial College are launching the first-ever searchable database of outcome measures intended for complementary and alternative medicine (CAM) researchers - the IN-CAM Outcomes Database.
The diabetes epidemic is devastating many areas of the world. In China, approximately 20 million people suffer from the disease - and the number keeps growing.